他克莫司患者中有11.7％的患者出现ACR70反应，而米唑瑞滨患者则没有。
11.7% of the tacrolimus patients had an ACR70 response compared with none of the mizoribine patients.
他克莫司可能与戊酸倍他米松一样有效（一种有效的类固醇）。
Tacrolimus is probably as strong as betamethasone valerate (a potent steroid).
目的探讨他克莫司对移植肝脏再灌注损伤的影响。
Objective to investigate the effects of tacrolimus on reperfusion injury in orthotopic liver transplantation.
眼镜框过敏性接触性皮炎：他克莫司可以预防复发吗？
Eyeglass frame allergic contact dermatitis: Does tacrolimus prevent recurrences?
他克莫司是一种用于器官移植患者的重要免疫抑制剂。
Tacrolimus is an important immunosuppressive drug for organ transplantation patients.
目的：观察他克莫司软膏对激素依赖性皮炎的治疗作用。
Objective To observe the effectiveness of Tacrolimus Ointment on corticosteroid-dependent dermitis.
他克莫司在固体分散体中可能以无定型态或分子状态存在。
Tacrolimus existed as amorphous or molecular state in tacrolimus solid dispersions.
目的探讨各因素对他克莫司温度敏感眼用凝胶体外释放的影响。
Objective to study the factors that influence the release of tacrolimus from the thermosensitive ophthalmic gel.
他克莫司治疗克罗恩病瘘管患者：一项随机，安慰剂对照试验。
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
结论他克莫司软膏外用治疗寻常型银屑病具有良好疗效和安全性。
Conclusion Tacrolimus ointment is effective, safe and tolerable in the topical treatment of psoriasis vulgaris.
摘要：目的探讨他克莫司对小鼠毛囊生长周期的影响及其作用机制。
ABSTRACT: Objective To explore the effect of tacrolimus on murine hair follicle cycle.
结果各种固体分散体均能大大增加他克莫司的溶解度，加快其体外溶出。
RESULTS The solubility and in vitro dissolution of all tacrolimus solid dispersions were increased significantly.
目的：评价0.03%他克莫司软膏治疗儿童特应性皮炎的疗效和安全性。
Objective: to evaluate the efficacy and safety of 0.03% tacrolimus ointment in the treatment of atopic dermatitis in children.
本发明公开了一种新的链霉菌、通过培养它制备他克莫司的方法及 其应用。
The invention discloses a new streptomycete, a method that prepares tacrolimus by cultivating the streptomycete and application of the method.
因此，监测他克莫司血药浓度非常重要，因为可判断临床疗效、避免毒副作用。
Hence, it is of the utmost importance to monitor tacrolimus blood concentration, thereby ensuring clinical effect and avoiding toxic side effects.
他克莫司是一种器官移植患者广泛使用的免疫抑制剂，大大提高了患者的生活质量和生存率。
Tacrolimus is an widely used immunosuppressant in organ transplant patients for anti-rejection, and the quality of life and survival rate are greatly enhanced.
方法用ELISA法测定他克莫司全血浓度，对138例患者的1190例次监测结果进行比较分析。
METHODS: The whole blood concentrations of tacrolimus were measured by ELISA. The levels of tacrolimus in 1190 samples from 138 liver transplant recipients were compared and studied.
塞特鲁洛表示，其中一种是他克莫司，这种药似乎会加速神经再生，或许有助于恢复移植器官发挥功能。
One of them, tacrolimus, seems to speed nerve regeneration and may help restore function to the transplant, Dr. Cetrulo said.
目的研究他克莫司结合蛋白-12（FKBP-12）在老年性痴呆模型小鼠及正常小鼠脑内表达量的差异。
Objective To observe the difference of FKBP-12 expression level between in Alzheimers disease model mices brains and in control mices brains.
结论他克莫司、雷帕霉素及抗白介素- 2r抗体联合用药，能够不同程度的提高胰岛细胞移植后糖尿病小鼠的存活时间。
Conclusion Combined with Tacrolimus, Rapamycin and anti IL-2R antibody immunosuppressive can prolong the graft survival in diabetic after islet transplantation.
在不相干的捐赠者移植中，使用喷司他丁，他克莫司和微型甲氨蝶呤预防移植物抗宿主疾病：一项I/II期对照，适应性随机研究。
Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study.
以他克莫司谷浓度测定结果结合器官移植受者的临床情况，比较MEIA法和ELISA法在心脏、肝脏、小肠和肾脏移植患者全血他克莫司谷浓度治疗窗的范围。
The MEIA and ELISA was used to detect tacrolimus valley point concentrations in heart, liver, small intestine and kidney transplantation recipients at different postoperative periods.
这也是真正的美国风湿病学会标准的50%的反应率（27.2%对2.0%）。另外，11.7%的他克莫司治疗组病人获得了美国风湿病学会标准的70%的反应率，而咪唑立宾组无一达到。
This was also true of the ACR50 response (27.2% versus 2.0%). In addition, 11.7% of the tacrolimus patients had an ACR70 response compared with none of the mizoribine patients.
这也是真正的美国风湿病学会标准的50%的反应率（27.2%对2.0%）。另外，11.7%的他克莫司治疗组病人获得了美国风湿病学会标准的70%的反应率，而咪唑立宾组无一达到。
This was also true of the ACR50 response (27.2% versus 2.0%). In addition, 11.7% of the tacrolimus patients had an ACR70 response compared with none of the mizoribine patients.
应用推荐